Gummies: Favored for their taste and ease of consumption, gummies are a good alternative for people who dislike swallowing pills
Now, Lilly recently reported topline results from the ATTAIN-1 phase-3 trial evaluating orforglipron, a once-daily oral glucagon-like-peptide-1 (GLP-1) receptor agonist for adults with obesity or overweight without diabetes
Scenario 2: Managing Side Effects Lets be honest, side effects like nausea can happen, especially during the initial titration phase
Industry impact: Suggested winners and losers The following table summarizes our predictions of the future impact of GLP-1 on various industries
A clinical pathway your biology has been waiting for
Skin whitening treatments are sought after not only for cosmetic reasons but also to address issues such as hyperpigmentation, dark spots, and uneven skin tone